Corrigendum to "Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea" (DOI:10.1016/j.antiviral.2008.09.007);Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

Antiviral Research

Volumn 81, Issue 1, 2009, Pages 68-76

  Rusnak, Janice M ^a   Byrne, William R ^a   Chung, Kyung N ^b   Gibbs, Paul H ^c   Kim, Theodore T ^b   Boudreau, Ellen F ^a   Cosgriff, Thomas ^a   Pittman, Philip ^a   Kim, Katie Y ^b   Erlichman, Marianne S ^d   Rezvani, David F ^c   Huggins, John W ^c  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b 121st General Hospital   (South Korea)

^c USAM RIID   (United States)

^d U S ARMY   (United States)

Author keywords

Hantaan; Hantavirus; HFRS; Korea; Ribavirin; Treatment

Indexed keywords

CALCIUM; CREATININE; DIPHENHYDRAMINE; MAGNESIUM; RIBAVIRIN;

ADULT; AMYLASE BLOOD LEVEL; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HANTAVIRUS; HEMATOCRIT; HEMOLYTIC ANEMIA; HUMAN; HYPERAMYLASEMIA; HYPERURICEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; LOADING DRUG DOSE; MALE; NECK RASH; OLIGURIA; PANCREATITIS; POLYURIA; PRIORITY JOURNAL; RASH; SIDE EFFECT; SINUS BRADYCARDIA; UPPER CHEST RASH; URIC ACID BLOOD LEVEL; VIRUS HEMORRHAGIC FEVER;

HANTAAN VIRUS; HANTAVIRUS;

EID: 57149094212     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.02.188     Document Type: Erratum

References (45)

1. Amitina R.Z. On the sinus bradycardia in hemorrhagic nephroso-nephritis. Terapevticheskii. Arkhiv. 34 (1962) 92-95
2. Basin B., Piperaud R., Guilbaud J.C., and Moussinga N. Bloc auriculo-ventriculaire chez deux patients atteints de fievre hemorragique avec syndrome renal (Nephropathies a Hantaan-Virus). Rev. Med. Intern. 13 (1992) 244-245
3. Bruno P., Hassell L.H., Brown J., Tanner W., and Lau A. The protean manifestations of hemorrhagic fever with renal syndrome: a retrospective review of 26 cases from Korea. Ann. Int. Med. 113 (1990) 385-391
4. Chapman L.E., Mertz G.J., Peters C.J., Jolson H.M., Khan A.S., Ksiazek T.G., Koster F.T., Baum K.F., Rollin P.E., Pavia A.T., Holman R.C., Christenson J.C., Rubin P.J., Behrman R.E., Bell L.J., Simpson G.L., Sadek R.F., and Ribavirin Study Group. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during one year of open label experience. Antivir. Ther. 4 (1999) 211-219
5. Chapman L.E., Ellis B.A., Koster F.T., Sotir M., Ksiazek T.G., Mertz G.J., Rollin P.E., Baum K.F., Pavia A.T., Christenson J.C., Rubin P.J., Jolson H.M., Behrman R.E., Khan A.S., Bell L.J., Simpson G.L., Hawk J., Holman R.C., Peters C.J., and Ribavirin Study Group. Discriminators between Hantavirus-infected and-uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin. Infect. Dis. 34 (2002) 293-304
6. Chiou H.E., Liu C.L., Buttrey M.J., Kuo H.P., Liu H.W., Kuo H.T., and Lu Y.T. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. Chest 128 (2005) 263-272
7. Chun P.K., and Godfrey L.J. Unique selective right atrial hemorrhage with epidemic (Korean) hemorrhagic fever. Am. Heart J. 108 (1984) 410-412
8. Chung, D., Sun, Y., Parker, W., Arterburn, J., Johnson, C.B., 2007. Ribavirin inhibits Hantaan virus via an extinction catastrophe rather than an error catastrophe mechanism. VII International Conference on HFRS, HPS, and Hantaviruses. Abstract 107, Buenos Aries, Argentina. June 15, 2007, p. 204.
9. Cosgriff T.M. Mechanisms of disease in hantavirus infection: pathophysiology of HFRS. Rev. Infect. Dis. 13 (1991) 97-107
10. Guang M.Y., Liu G.Z., and Cosgriff T.M. Hemorrhage in hemorrhagic fever with renal syndrome in China. Rev. Infect. Dis. 11 S4 (1989) S884-S890
11. Huggins J.W., Kim G.R., Brand O.M., and McKee K.T. Ribavirin therapy for Hantaan virus infection in suckling mice. J. Infect. Dis. 153 (1986) 489-497
12. Huggins J.W. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev. Infect. Dis. 11 S4 (1989) S750-S761
13. Huggins J.W., Hsiang C.M., Cosgriff T.M., Guang M.Y., Smith J.I., Wu Z.O., LeDuc J.W., Zheng Z.M., Meegan J.M., Wang Q.N., Oland D.D., Gui X.E., Gibbs P.H., Yuan H.Y., and Zhang T.M. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 64 (1991) 1119-1127
14. Hullinghorst R.L., and Steer A. Pathology of epidemic hemorrhagic fever. Ann. Intern. Med. 38 (1953) 77-101
15. Investigator's Brochure. Ribavirin, 1989. Viratek Inc., Costa Mesa, CA. FDA: Amendment-062 revised August 11, 1989.
16. Investigational Drug Brochure, 2004. Virazole (Ribavirin, USP) injection, 100 mg/mL. IND 9076. Fourth edition. Valeant Pharmaceuticals International, Costa Mes, CA.
17. Kanerva M., Mustonen J., and Vaheri A. Pathogenesis of Puumala and other hantavirus infections. Rev. Med. Virol. 8 (1998) 67-86
18. Katetanovic B., Ridanovic Z., Petrovic O., and Arslanagic A. ECG in patients with haemorrhagic fever. Medicinski. Arhiv. 46 (1992) 64-65
19. Kessler W.H. Gross anatomic features found in 27 autopsies of epidemic hemorrhagic fever. Ann. Intern. Med. 38 (1953) 73-76
20. Kim Y.K., Lee S.C., Kim C.S., Heo S.T., Choi C.M., and Kim J.M. Clinical characteristics and predictors of acute oliguric renal failure in hemorrhagic fever with renal syndrome. Korean J. Med. 70 (2006) 190-195
21. Knowles S.R., Phillips E.J., Dresser L., and Matukas L. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin. Infect. Dis. 37 (2003) 1139-1142
22. Kompanets, G., Slonova, R., Lunikhina, O., 2007. Influence of the conditions of airborne mode of hantavirus transmission on the severity of HFRS. VII International Conference on HFRS, HPS, and Hantaviruses. Abstract 6. Buenos Aries, Argentina. June 15, 2007, p. 94.
23. Koren G., King S., Knowles S., and Phillips E. Ribavirin in the treatment of SARS: a new trick for an old drug?. Canadian Med. Assn. J. 168 (2003) 1289-1292
24. LeDuc J.W., Ksiazek T.B., Rossi C.A., and Dalrymple J.M. A retrospective analysis of sera collected by the hemorrhagic fever commission during the Korean Conflict. J. Infect. Dis. 162 (1990) 1182-1184
25. Lee H.W. Epidemiology and epizoology. In: Lee H.W., Calisher C., and Schmaljohn C. (Eds). Manual of Hemorrhagic Fever With Renal Syndrome and Hantavirus Pulmonary Syndrome (1999), WHO Collaborating Center for Virus Reference and Research (Hantaviruses), Asan Institute for Life Sciences, Seoul 40-48
26. Lee J.S. Clinical features of hemorrhagic fever with renal syndrome in Korea. Kidney Int. 40 (1991) S88-S93
27. Lewis R.M., Lee H.W., See A.F., Parrish D.B., Moon J.S., Kim D.J., and Cosgriff T.M. Changes in population of immune effector cells during the course of HFRS. Trans. R. Soc. Trop. Med. Hyg. 85 (1990) 282-286
28. Liu Y.H., Huang J.H., Hsueh P.R., and Luh K.T. Hantavirus infection with marked sinus bradycardia, Taiwan [Letter to the editor]. Emerg. Infect. Dis. 8 (2002) 644
29. Lukes R.J. The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am. J. Med. 16 (1954) 639-650
30. Markotic A., Nichol S.T., Kuzman I., Sanchez A.J., Ksiazek T.G., Gagro A., Rabatic S., Zgorelec R., Avsic-Zupanc T., Beus I., and Dekaris D. Characteristics of Puumala and Dobrava infections in Croatia. J. Med. Virol. 66 (2002) 542-551
31. McEvoy G.K., Miller J., and Litvak K. AHFS Drug Information; 2004 (2004), American Society of Health-System Pharmacists Inc., Bethesda, MD
32. McKee K.T., Huggins J.W., Trahan C.J., and Mahlandt B.G. Ribavirin prophylaxis and therapy for experimental argentine fever. Antimicrob. Agents Chemother. 32 (1988) 1304-1309
33. Muller M.P., Dresser L., Raboud J., McGeer A., Rea E., Richardson S.E., Mazzulli T., Loeb M., and Louie M. Adverse events associated with high-dose ribavirin: evidence from Toronto outbreak of severe acute respiratory syndrome. Pharmocotherapy 27 (2007) 494-502
34. Mustonen J., Brummer-Korvenkontio M., Hedman K., Pasternack A., Pietila K., and Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand. J. Infect. Dis. 26 (1994) 7-13
35. Mustonen J., Helin H., Pietila K., Brummer-Korvenkontio M., Hedman K., Vaheri A., and Pasternack A. Renal biopsy findings and clinicopathologic correlations in nephropathica epidemica. Clin. Nephrol. 41 (1994) 121-126
36. Mustonen J., Partanen J., Kanerva M., Pietila K., Vapalahiti O., Pasternack A., and Vaheri A. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 49 (1996) 217-221
37. Mustonen J., Partanen J., Kanerva M., Pietila K., Vapalahti O., Pasternack A., and Vaheri A. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand. J. Immunol. 47 (1998) 277-279
38. Pal E., Strle F., and Avsic-Zupanc T. Hemorrhagic fever with renal syndrome in the Pomurje region of Slovenia- an 18-year survey. Wien. Klin. Wochenschr. 117 (2005) 398-405
39. Peters C.J., Simpson G.L., and Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Ann. Rev. Med. 50 (1999) 531-545
40. Pimenov L.T., Dudarev M.V., and Eshmakov S.V. Clinicofunctional characteristics of the heart in haemorrhagic fever with renal syndrome. Klin. Med. 80 (2002) 28-31
41. Puljiz I., Kuzman I., Markotic A., Turcinov D., Matic M., and Makek N. Electrocardiographic changes in patients with haemorrhagic fever with renal syndrome. Scand. J. Infect. Dis. 37 (2005) 594-598
42. Smadel J.E. Epidemic haemorrhagic fever. Am. J. Publ. Health 43 (1951) 1327-1330
43. Takala A., Lahdevirta J., Jansson S., Vapalahti O., Orpana A., Karonen S., and Repo H. Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J. Infect. Dis. 181 (2000) 1964-1970
44. Zhang X.L., Wong X.H., Liu C.Z., Jin W.E., Xiong K.J., and Luo D.D. Detection of viral antigens in various organs in 14 fatal cases of epidemic hemorrhagic fever. J. Intern. Med. 26 (1987) 461-463
45. Zhang T.M., Yang Z.Q., Zhong M.Y., Hu Z.J., Hiang J.M., Huggins J.W., Cosgriff T.M., and Smith J.I. Early analysis of viremia and clinical tests in patients with epidemic hemorrhagic fever. Chin. Med. J. 106 (1993) 608-610